Sanne Thougaard

Angella Invest is an education and investor community providing advisory services to families, nextgens and exited founders/company owners. We also have the largest community of women angel investors in Denmark. Our focus is financial education within alternative investments, wealth management activities and family investment matters.

Innovation Fund Denmark connects research, knowledge and ideas with the businesses and society that need them.

Antler is one of the most active early-stage investors globally. The firm leads in ‘Day Zero’ investing, an approach to venture capital focused on partnering with founders pre-launch. Antler systematically removes capital and network constraints for early-stage technology entrepreneurs by providing co-founder matching, deep business model validation, initial capital, expansion support, and follow-on funding. The firm is present in 27 cities across most leading technology ecosystems globally and has made over 1,300 investments into early-stage startups. Antler has been repeatedly recognized by Pitchbook as the world’s most active angel and seed-stage investor.

Angella Invest is an education and investor community providing advisory services to families, nextgens and exited founders/company owners. We also have the largest community of women angel investors in Denmark. Our focus is financial education within alternative investments, wealth management activities and family investment matters.

Lundbeck is a biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, we are committed to improving the lives of people with neurological and psychiatric diseases. Brain disorders affect a large part of the world’s population, and the effects are felt throughout society. With the rapidly improving understanding of the biology of the brain, we hold ourselves accountable for advancing brain health by curiously exploring new opportunities for treatments. As a focused innovator, we strive for our research and development programs to tackle some of the most complex neurological challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology. We are committed to fighting stigma and we act to improve health equity. We strive to create long term value for our shareholders by making a positive contribution to patients, their families and society as a whole. Lundbeck has more than 5,000 employees in more than 20 countries and our products are available in more than 80 countries. For additional information, we encourage you to visit our corporate site www.lundbeck.com

We’re on a mission to make mental health accessible, affordable and for everyone. Steps builds digital tools to help people overcome the fear of being judged by others using principles from exposure therapy.